Mechanisms of heparanase inhibition by the heparan sulfate mimetic PG545 and three structural analogues
Year: 2013
Type: article
Abstract: The tetrasaccharide heparan sulfate (HS) mimetic PG545, a clinical anti-cancer candidate, is an inhibitor of the HS-degrading enzyme heparanase. The kinetics of heparanase inhibition by PG545 and three structural analogues were investigated to understand their modes of inhibition. The cholestanol aglycon of PG545 significantly increased affinity for heparanase and also modified the inhibition mode. For the tetrasaccharides, competitive inhibition was modified to parabolic competition by the addition of the cholestanol aglycon. For the trisaccharides, partial competitive inhibition was modified to parabolic competition. A schematic model to explain these findings is presented.
Source: FEBS Open Bio
Authors: Edward Hammond, Paul Handley, Keith Dredge, Ian Bytheway
Institution: The University of Queensland
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,210
OpenAlex ID: W2005175992
